🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fixed-Dose Combination (FDC) Tablet

Found 0 matching trials

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of a fixed dose...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01463228

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

PHASE2

The purpose of this study was to assess the efficacy of a fixed dose combin...

Status

Completed

Location

Ucsd, Avrc Crs (701)

Start Date

2019-11-20

Trial ID

NCT04042740

Treatments Being Tested

Glecaprevir/Pibrentasvir (G/P)

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

PHASE3

Combination therapy in pulmonary arterial hypertension (PAH) has been the s...

Status

Completed

Location

Providence Medical Foundation

Start Date

2019-07-29

Trial ID

NCT03904693

Treatments Being Tested

FDC macitentan/tadalafil Macitentan 10 mg Tadalafil 40 mg Placebo FDC Placebo macitentan Placebo tadalafil

A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

PHASE2

To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...

Status

Completed

Location

Multiple Locations

Start Date

2016-02

Trial ID

NCT02508207

Treatments Being Tested

Tezacaftor/Ivacaftor Ivacaftor Tezacaftor/Ivacaftor matching placebo Ivacaftor matching placebo

Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects

PHASE3

This study examines the bioavailability and bioequivalence of single dose o...

Status

Completed

Location

Sarfez Pharmaceuticals

Start Date

2025-07-01

Trial ID

NCT07015671

Treatments Being Tested

10 mg Torsemide tablet 25 mg Aldactone (Spironolactone) tablet FDC (12 mg ER Torsemide + 15mg Spironolactone) tablet

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

PHASE4

PRECIOUS Study aims to evaluate the efficacy and safety of therapy with fix...

Status

Completed

Location

Unimed medical center

Start Date

2018-02-13

Trial ID

NCT03738761

Treatments Being Tested

Amlessa®Co-Amlessa®

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of fixed dose c...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01454622

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

PHASE2

The primary objective of this study is to evaluate the efficacy of oral wee...

Status

Active Not Recruiting

Location

Pacific Oaks Medical Group

Start Date

2021-10-05

Trial ID

NCT05052996

Treatments Being Tested

ISL LEN B/F/TAF ISL/LEN FDC

Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)

PHASE1

To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...

Status

Completed

Location

Mds Pharma Services

Start Date

2009-06

Trial ID

NCT00897390

Treatments Being Tested

Saxagliptin Metformin IR (glucophage)Saxagliptin + Metformin IR (FDC)

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

PHASE2

The goal of this clinical study is to learn more about the effects of switc...

Status

Active Not Recruiting

Location

Be Well Medical Center

Start Date

2022-08-16

Trial ID

NCT05502341

Treatments Being Tested

Bictegravir Lenacapavir BIC/LEN FDC Stable Baseline Regimen

Previous Next